The trademark application MELIDUO was filed by Nordisk Pharma, a corporation established under the laws of the Kingdom of Denmark (the "Applicant"). The application was published for oppositions on October 10, 2022, and it was registered by office on January 17, 2023 without any oppositions.
The application was filed in Danish (English was selected as the second language).